Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-10

Clinical Trial Update: Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 pragmatic randomized trial comparing aripiprazole, olanzapine, and haloperidol for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)
  • Haldol (haloperidol)
  • Zyprexa (olanzapine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED